Advertisement

Topics

Ipsen and Saol partner to co-promote Dysport in US

19:00 EDT 2 Jul 2017 | Pharmaceutical Technology

The US affiliate of French pharmaceutical company Ipsen has entered an exclusive, three-year agreement with Saol Therapeutics to promote Dysport (abobotulinumtoxinA) for approved therapeutic indications in adult spasticity and pediatric lower limb sp…

Original Article: Ipsen and Saol partner to co-promote Dysport in US

NEXT ARTICLE

More From BioPortfolio on "Ipsen and Saol partner to co-promote Dysport in US"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...